| association id |
FEATURE |
Drug id |
Propr |
Public |
Drug Name |
Drug Target |
N FEATURE pos |
N FEATURE neg |
log max Conc tested |
FEATURE neg logIC50 MEAN |
FEATURE pos logIC50 MEAN |
FEATURE deltaMEAN IC50 |
FEATURE IC50 effectSize |
FEATURE neg Glass delta |
FEATURE pos Glass delta |
ANOVA FEATURE pval |
Tissue ANOVA pval |
MSI ANOVA pval |
ANOVA FEATURE FDR % |
a109 |
loss_cnaPANCAN307_(CHD3,GPS2,TP53) |
179 |
1 |
1 |
5-Fluorouracil |
DNA antimetabolite |
103 |
810 |
3.47 |
3.52 |
3.9 |
0.381 |
0.21 |
0.21 |
0.21 |
1.71e-05 |
1.12e-45 |
2.31e-01 |
2.6 |
a220 |
loss_cnaPANCAN359_(CUL3) |
179 |
1 |
1 |
5-Fluorouracil |
DNA antimetabolite |
19 |
894 |
3.47 |
3.53 |
5.1 |
1.57 |
0.89 . |
0.88 . |
1.4 * |
1.06e-04 |
1.73e-45 |
2.31e-01 |
7.9 |
a262 |
loss_cnaPANCAN326_(SOX9) |
179 |
1 |
1 |
5-Fluorouracil |
DNA antimetabolite |
10 |
903 |
3.47 |
3.54 |
5.39 |
1.85 |
1 * |
1 * |
1.8 * |
1.74e-04 |
1.95e-45 |
2.32e-01 |
11 |
a309 |
loss_cnaPANCAN304 |
179 |
1 |
1 |
5-Fluorouracil |
DNA antimetabolite |
73 |
840 |
3.47 |
3.54 |
3.78 |
0.233 |
0.13 |
0.13 |
0.13 |
2.71e-04 |
2.17e-45 |
2.32e-01 |
14 |
a393 |
loss_cnaPANCAN306 |
179 |
1 |
1 |
5-Fluorouracil |
DNA antimetabolite |
73 |
840 |
3.47 |
3.54 |
3.77 |
0.225 |
0.13 |
0.13 |
0.13 |
4.4e-04 |
2.44e-45 |
2.32e-01 |
19 |
a406 |
loss_cnaPANCAN305 |
179 |
1 |
1 |
5-Fluorouracil |
DNA antimetabolite |
73 |
840 |
3.47 |
3.55 |
3.74 |
0.199 |
0.11 |
0.11 |
0.11 |
4.84e-04 |
2.49e-45 |
2.32e-01 |
20 |
a414 |
gain_cnaPANCAN363_(ASXL1) |
179 |
1 |
1 |
5-Fluorouracil |
DNA antimetabolite |
99 |
814 |
3.47 |
3.47 |
4.35 |
0.884 |
0.5 . |
0.49 |
0.6 . |
5.01e-04 |
2.51e-45 |
2.32e-01 |
20 |
a416 |
loss_cnaPANCAN360 |
179 |
1 |
1 |
5-Fluorouracil |
DNA antimetabolite |
26 |
887 |
3.47 |
3.53 |
4.62 |
1.09 |
0.61 . |
0.61 . |
0.77 . |
5.08e-04 |
2.52e-45 |
2.32e-01 |
20 |
a502 |
loss_cnaPANCAN227, loss_cnaPANCAN228 |
179 |
1 |
1 |
5-Fluorouracil |
DNA antimetabolite |
30 |
883 |
3.47 |
3.52 |
4.8 |
1.29 |
0.73 . |
0.72 . |
1 * |
7.28e-04 |
2.75e-45 |
2.32e-01 |
24 |
